The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
|
---|---|
Published in |
Experimental Hematology & Oncology, May 2023
|
DOI | 10.1186/s40164-023-00409-y |
Pubmed ID | |
Authors |
Xiaohui Suo, Fang Zheng, Dongmei Wang, Liyun Zhao, Jie Liu, Ling Li, Zhihua Zhang, Congcong Zhang, Yinling Li, Sisi Yang, Xuemei Zhao, Rui Shi, Yan Wu, Zongjiu Jiao, Jiaojie Song, Ling Zhang, Xinxiao Lu, Linyu Yuan, Sifeng Gao, Jilei Zhang, Xingli Zhao, Guanchen Bai, Kaiqi Liu, Yingchang Mi |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Ecuador | 2 | 5% |
Argentina | 2 | 5% |
United States | 2 | 5% |
India | 2 | 5% |
Brazil | 1 | 3% |
Singapore | 1 | 3% |
Canada | 1 | 3% |
Spain | 1 | 3% |
Mexico | 1 | 3% |
Other | 1 | 3% |
Unknown | 23 | 62% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 27 | 73% |
Practitioners (doctors, other healthcare professionals) | 6 | 16% |
Scientists | 3 | 8% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 1 | 11% |
Unknown | 8 | 89% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 1 | 11% |
Unknown | 8 | 89% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2023.
All research outputs
#1,534,087
of 25,985,060 outputs
Outputs from Experimental Hematology & Oncology
#11
of 389 outputs
Outputs of similar age
#30,837
of 404,167 outputs
Outputs of similar age from Experimental Hematology & Oncology
#1
of 16 outputs
Altmetric has tracked 25,985,060 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 389 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,167 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.